These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Practical value of active prospective monitoring of drug therapy safety]. Ovchinnikova EA; Nazimkin KE; Iagudina RI Antibiot Khimioter; 2006; 51(9-10):40-6. PubMed ID: 18030790 [No Abstract] [Full Text] [Related]
7. Preventing extravasation during administration of antineoplastic drugs. Stevenson DF; Emmrich BF; Lucas VS Oncol Nurs Forum; 1985; 12(2):83. PubMed ID: 3845606 [No Abstract] [Full Text] [Related]
8. Preventing extravasation from central venous catheters. Denner AM; Townley SA Anaesthesia; 2006 Jun; 61(6):614-5. PubMed ID: 16704615 [No Abstract] [Full Text] [Related]
10. Implementation of a protocol for the prevention and management of extravasation injuries in the neonatal intensive care patient. Warren D Int J Evid Based Healthc; 2011 Jun; 9(2):165-71. PubMed ID: 21599845 [TBL] [Abstract][Full Text] [Related]
11. Preventing extravasation from a central line. Hadaway LC Nursing; 2004 Jun; 34(6):22-3. PubMed ID: 15209067 [No Abstract] [Full Text] [Related]
12. Antineoplastic agents extravasation from peripheral intravenous line in children: a simple strategy for a safer nursing care. Chanes DC; da Luz Gonçalves Pedreira M; de Gutiérrez MG Eur J Oncol Nurs; 2012 Feb; 16(1):17-25. PubMed ID: 21440502 [TBL] [Abstract][Full Text] [Related]
13. Comment on: management of chemotherapy extravasation: ESMO-EONS clinical practice guidelines. Conde-Estévez D; Mateu-de Antonio J Ann Oncol; 2013 Apr; 24(4):1128-9; author reply 1129-30. PubMed ID: 23393123 [No Abstract] [Full Text] [Related]
14. Reply to 'Comment on: management of chemotherapy extravasation: ESMO-EONS clinical practice guidelines'. Pérez-Fidalgo JA; Cervantes A Ann Oncol; 2013 Apr; 24(4):1129-30. PubMed ID: 23406727 [No Abstract] [Full Text] [Related]
15. Nursing role model for computed tomography contrast injection decreases extravasation rates. Kadom N; Hashim HD; Olsen C; Cefaratti M; Bulas D; Shalaby-Rana E J Pediatr Nurs; 2012 Apr; 27(2):113-8. PubMed ID: 22341189 [TBL] [Abstract][Full Text] [Related]
17. Preventing adverse drug reactions in the general population. Pezalla E Manag Care Interface; 2005 Oct; 18(10):49-52. PubMed ID: 16265935 [TBL] [Abstract][Full Text] [Related]
18. Current recommendations for prevention and therapy of extravasation reactions in dermato-oncology. Kähler KC; Mustroph D; Hauschild A J Dtsch Dermatol Ges; 2009 Jan; 7(1):21-8. PubMed ID: 18479476 [TBL] [Abstract][Full Text] [Related]
19. Vesicant extravasation part I: Mechanisms, pathogenesis, and nursing care to reduce risk. Sauerland C; Engelking C; Wickham R; Corbi D Oncol Nurs Forum; 2006 Nov; 33(6):1134-41. PubMed ID: 17149396 [TBL] [Abstract][Full Text] [Related]
20. Infiltration and extravasation: update on prevention and management. Doellman D; Hadaway L; Bowe-Geddes LA; Franklin M; LeDonne J; Papke-O'Donnell L; Pettit J; Schulmeister L; Stranz M J Infus Nurs; 2009; 32(4):203-11. PubMed ID: 19605999 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]